Related Experiment Video
Updated: Aug 25, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
[Factors affecting prognosis in childhood Guillain Barré syndrome]
1Instituto de Ortopedia Infantil Roosevelt, Bogota, Colombia. fortiz200@hotmail.com
Insights
Guillain Barré syndrome (GBS) in children with quadriplegia and electrical non-excitability by day 10 indicates a poor prognosis. These children experience significantly longer motor recovery times compared to those with excitable motor nerves.
Area of Science:
- Neurology
- Pediatrics
- Clinical Electrophysiology
Context:
- Guillain Barré syndrome (GBS) is a leading cause of acute flaccid paralysis in children.
- Prognostic factors for GBS in Latin America remain underexplored.
- This study focuses on pediatric GBS patients in a tertiary care setting.
Purpose:
- To identify clinical and electrophysiological indicators of GBS prognosis in children.
- To evaluate factors influencing recovery time in pediatric GBS patients.
- To correlate early disease indicators with long-term functional outcomes.
Summary:
- A prospective study of 67 pediatric GBS patients identified protracted plateau time, day 10 quadriplegia, and electrical non-excitability as linked to prolonged recovery.
- Kaplan-Meier and Cox analyses revealed quadriplegia with electrical non-excitability significantly predicted longer recovery to Hughes stage III (mean 172.7 days).
- Conversely, patients with excitable motor nerves and no quadriplegia achieved functional recovery faster (mean 39.51 days).
Impact:
- Identifies specific clinical and electrophysiological markers for predicting GBS recovery in children.
- Highlights the poor prognosis associated with quadriplegia and electrical non-excitability in pediatric GBS.
- Provides valuable data for prognostic assessment and management strategies in pediatric neurology.
Introduction:
Guillain Barré syndrome (GBS) is the most frequent cause of acute flaccid paralysis in children. The factors that come to bear on its prognosis have not been properly determined in Latin America.
Aims:
Our aim was to establish the clinical and electrophysiological indicators of GBS in a group of paediatric patients attended in a tertiary care hospital. Patients and methods. We conducted a prospective study involving 67 patients who were hospitalised in the Instituto de Ortopedia Infantil Roosevelt between 1999 and 2002 after having been diagnosed as suffering from GBS. The clinical and electrophysiological characteristics were evaluated during the first month of illness and a clinical follow up was carried out until the patients reached stage III on Hughes' functional disability scale.
Results:
Initially, it was observed that the protracted plateau time, the quadriplegia on day 10 of the disease and the electrical non excitability demonstrated by means of neuroconduction studies were variables linked to a protracted recovery time. Patients with a protracted recovery time required respiratory assistance more often, but this association was not statistically significant. In the Kaplan Meier survival analysis and the Cox analysis employed to determine the effects of covariance, the presence of quadriplegia associated to electrical non excitability were identified as significant variables in nine patients who required a longer time to reach Hughes stage III (mean: 172.7 days, 95% confidence intervals: 143.51 202.05). Patients with excitable motor nerves (EMN) and without quadriplegia reached functional stage III more quickly (mean: 39.51 days, 95% confidence intervals: 25.79 53.24).
Conclusions:
Children with GBS who display EMN and quadriplegia on day 10 of the illness are the group with the poorest prognosis and have a very long motor recovery time.
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Botulism
Secondary Spinal Cord Injury llI: Pathophysiology
